Cantor Fitzgerald Reiterates Neutral on Aspira Womens Health, Maintains $4 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Ross Osborn has reiterated a Neutral rating on Aspira Womens Health (NASDAQ:AWH) and maintained a $4 price target.

September 26, 2023 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cantor Fitzgerald analyst maintains a Neutral rating and $4 price target on Aspira Womens Health.
The news directly pertains to Aspira Womens Health (AWH) as Cantor Fitzgerald analyst Ross Osborn has reiterated a Neutral rating on the company and maintained a $4 price target. This suggests that the analyst sees the stock as fairly valued at its current price, which could influence investor sentiment and trading behavior. However, as this is a reiteration of a previous rating and price target, it may not have a significant impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100